Form 4 for EFX Equifax
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001225208-24-001926 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-09 | EFX | Begor Mark W | CEO, Dir | A - Grant | $0.00 | +8,107 | 71.2K | +13% | $0 |
| DM | 2024-02-13 | 2024-02-09 | EFX | Begor Mark W | CEO, Dir | A - Grant | $0.00 | +29.8K | 15.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | A | A | 8,107 | $0.00 | 71,204 | D | — | — | (F1) Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 2 | Derivative | Stock Option/Right to Buy | 2024-02-09 | A | A | 14,097 | $0.00 | 14,097 | D | $274.10 · — to 2031-02-09 | 14,097 Common Stock | (F3) Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025. |
| 3 | Derivative | Stock Option/Right to Buy | 2024-02-09 | A | A | 15,662 | $0.00 | 15,662 | D | $299.02 · — to 2031-02-09 | 15,662 Common Stock | (F3) Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025. |